太阳能：拟1亿-2亿元回购股份用于注销 5月26日晚，太阳能（000591）发布公告称，公司拟使用自筹资金以集中竞价交易方式回购部分A股股 份，用于依法注销减少注册资本。回购资金总额不低于1亿元且不高于2亿元，回购价格不超过6.69元/ 股。 资料显示，太阳能成立于1993年4月，主营业务是光伏电站的投资运营，光伏电池、组件的研发、生产 和销售。 所属行业：公用事业–电力–光伏发电 润阳科技：拟3亿元增资上海傅利叶智能科技有限公司 5月26日晚，润阳科技（300920）发布公告称，公司拟与上海傅利叶智能科技有限公司签订《投资意向 协议》，以不超过3亿元的现金增资傅利叶，傅利叶投前估值为80亿元。 资料显示，润阳科技成立于2012年10月，主营业务是聚烯烃发泡材料的研发、生产及销售。 所属行业：基础化工–塑料–其他塑料制品 恒瑞医药：子公司SHR-4712注射液临床试验获得批准 5月26日晚，恒瑞医药（600276）发布公告称，子公司广东恒瑞医药有限公司、上海盛迪医药有限公司 收到国家药品监督管理局核准签发的SHR-4712注射液《药物临床试验批准通知书》，即将开展治疗晚 期实体瘤的临床试验。 资料显示，恒瑞医 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688231 证券简称：隆达股份 公告编号：2025-021 江苏隆达超合金股份有限公司 关于对新加坡全资子公司增加投资的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 投资标的名称：SINGDA SUPERALLOY PTE. LTD. ● 本次增加投资金额：4,000万美元 ● 相关风险提示： 1、江苏隆达超合金股份有限公司（以下简称"公司"或"隆达股份"）本次对新加坡全资子公司SINGDA SUPERALLOY PTE. LTD.（以下简称"新达公司"）增加投资事宜尚需履行境内对境外投资的审批或备 案等手续，能否顺利实施存在不确定性。 2、鉴于本次增加投资的资金来源均为自有资金，可能存在自有资金实际投入与项目计划所需资金投入 进度不匹配的风险，公司将持续关注项目建设进度，合理安排资金支出。 3、因受宏观经济、行业发展、政策等因素影响，可能会出现项目实际建设进度及投产后产能利用不达 预期的风险，导致本次项目投资收益存在不确定性，公司将 ...

证券代码：688231 证券简称：隆达股份 公告编号：2025-021 江苏隆达超合金股份有限公司 关于对新加坡全资子公司增加投资的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 1、江苏隆达超合金股份有限公司（以下简称"公司"或"隆达股份"）本 次对新加坡全资子公司 SINGDA SUPERALLOY PTE. LTD.（以下简称"新达公 司"）增加投资事宜尚需履行境内对境外投资的审批或备案等手续，能否顺利 实施存在不确定性。 2、鉴于本次增加投资的资金来源均为自有资金，可能存在自有资金实际投 入与项目计划所需资金投入进度不匹配的风险，公司将持续关注项目建设进度， 合理安排资金支出。 3、因受宏观经济、行业发展、政策等因素影响，可能会出现项目实际建设 进度及投产后产能利用不达预期的风险，导致本次项目投资收益存在不确定性， 公司将进一步强化对项目的管理工作，持续关注相关子公司的经营状况及管理 成果，积极防范应对和控制上述风险。 一、对外投资及其进展情况的概述 公司于 2024 年 1 月 16 日召开 ...

证券代码：688231 证券简称：隆达股份 公告编号：2025-020 江苏隆达超合金股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 5 月 16 日 （二） 股东大会召开的地点：无锡市锡山区安镇街道翔云路 18 号，隆达股份公 司会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 59 | | --- | --- | | 普通股股东人数 | 59 | | 2、出席会议的股东所持有的表决权数量 | 120,964,627 | | 普通股股东所持有表决权数量 | 120,964,627 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 49.0018 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 49.0018 | ...

北京大成(上海)律师事务所 关于江苏隆达超合金股份有限公司 2024 年年度股东大会的 = 法律意见书 大成 DENTONS 大成 is Dentons' Preferred Law Firm in China. 北京大成(上海)律师事务所 www.dacheng.com 上海市世纪大道 100 号环球金融中心 9 层、24 层、25 层(200120) 9th/24th/25th Floor, Shanghai World Financial Center, 100 Century Avenue Shanghai 200120, P. R. China Tel: +86 21 5878 5888 Fax: +86 21 5878 6866 江苏隆达超合金股份有限公司 2024年年度股东大会法律意见书 江苏隆达超合金股份有限公司 2024年年度股东大会法律意见书 北京大成(上海)律师事务所 关于江苏降达韶合金股份有限公司 2024 年年度股东大会的法律意见书 致:江苏隆达超合金股份有限公司 根据《中华人民共和国证券法》(以下简称"《证券法》")《中华人民共和国 公司法》(以下简称"《公司法》")和中国证券监督 ...

Investment Rating - The report maintains a "Strong Buy" rating for the company [1] Core Insights - In 2024, the company achieved a revenue of 1.391 billion yuan, a year-on-year increase of 15.22%, and a net profit attributable to shareholders of 66.114 million yuan, up 19.38% year-on-year [1][4] - The company's non-recurring net profit saw a significant increase of 51.21% year-on-year, reaching 44.381 million yuan [1] - The first quarter of 2025 showed a revenue of 344 million yuan, reflecting an 8.67% year-on-year growth, with a net profit of 28.539 million yuan, up 3.20% year-on-year [1] Financial Performance - The company reported a gross margin of 15.88% in 2024, an increase of 0.51 percentage points year-on-year, and a net margin of 4.75%, up 0.17 percentage points year-on-year [4] - The revenue from high-temperature alloys reached 897 million yuan, a year-on-year increase of 23.96%, with a production volume of 4,013.71 tons, up 28.28% year-on-year [4] - The aerospace sector generated 435 million yuan in revenue, a 46.64% increase year-on-year, while the gas turbine sector saw a revenue increase of 67.34% to 267 million yuan [4] International Expansion - The company is actively expanding its international presence, with overseas revenue reaching 262 million yuan, a remarkable year-on-year increase of 167.84% [4] - The establishment of production bases in Singapore and Malaysia is underway, with land transaction contracts signed for the Malaysian facility [5] Future Projections - The company forecasts net profits of 99 million yuan, 129 million yuan, and 162 million yuan for 2025, 2026, and 2027 respectively, with corresponding PE ratios of 41, 31, and 25 [5][6] - Revenue is expected to grow to 1.75 billion yuan in 2025, reflecting a 26% year-on-year increase [6]

Group 1 - Shengyi Electronics plans to repurchase shares with a total amount between 50 million and 100 million yuan, at a price not exceeding 43.02 yuan per share, for employee stock ownership plans [1] - Guoyao Modern's subsidiary has passed the consistency evaluation for the quality and efficacy of a generic drug, which is used for treating severe infections [1] - Tianhe Magnetic Materials' subsidiaries have obtained project filing notices for high-performance rare earth permanent magnet projects, with total investments of 100 million yuan and 50 million yuan respectively [1][2] Group 2 - Dream Lily intends to repurchase shares with an amount between 85 million and 170 million yuan, at a price not exceeding 10.90 yuan per share, supported by a loan commitment of up to 150 million yuan [3] - Weifu High-Tech has received a loan commitment of up to 135 million yuan from a financial institution for share repurchase [3] Group 3 - Lu'an Environmental Energy reported a coal sales volume of 4.51 million tons in April, a year-on-year increase of 17.75% [5] - *ST Tianshan reported a significant decline in livestock sales and revenue, with a revenue of 70,500 yuan in April, down 95.68% year-on-year [7] Group 4 - Feirongda announced a cash dividend of 0.38 yuan per 10 shares, with a total distribution of 21.9 million yuan [8] - Zhejiang Rongtai's shareholders and executives plan to reduce their holdings by up to 1.93% of the company's shares [9] Group 5 - Changhua Group's subsidiary won the land use rights for an industrial site in Ningbo for 27.05 million yuan, intended for manufacturing and related business [11] - Zejing Pharmaceutical's new drug application for a treatment for severe alopecia has been accepted by the regulatory authority [13][14] Group 6 - Hainan Mining plans to distribute a cash dividend of 0.8 yuan per 10 shares, totaling 1.59 billion yuan [15] - China Jushi plans to distribute a cash dividend of 0.24 yuan per share, totaling 9.61 billion yuan [16] Group 7 - Zhengzhong Design's subsidiary has obtained a utility model patent for an acrylic signage guide [18] - Rundu Co., Ltd. received approval for a veterinary drug product, which is intended for treating bacterial diseases in livestock [20] Group 8 - Emei Mountain A announced the resignation of its general manager due to work reasons [22] - Tonghua Dongbao's insulin injection has received a registration certificate in Nicaragua, allowing for sales in that market [23] Group 9 - Dizu Fashion's subsidiary has completed the registration of a private equity investment fund [24] - Ningbo Gaofa plans to increase capital by 60 million yuan in its subsidiary for operational needs [26] Group 10 - Haichuan Intelligent has obtained two utility model patents for material handling devices [27] - Newland's subsidiary signed a deep cooperation agreement with Alibaba Cloud for AI model applications [29] Group 11 - Rui Neng Technology's controlling shareholder plans to reduce its stake by up to 2.89% [30] - Guomai Culture intends to repurchase shares between 50 million and 100 million yuan for capital reduction [31] Group 12 - Shaanxi Construction won major construction projects totaling 7.88 billion yuan in April [32] - Hanyu Pharmaceutical signed a joint development agreement for a new peptide drug with a partner [34] Group 13 - Yunnan Copper is planning to acquire a 40% stake in Liangshan Mining, leading to a stock suspension [35] - Haizheng Pharmaceutical plans to repurchase shares between 50 million and 100 million yuan for employee stock ownership [36] Group 14 - Tianqiao Hoisting's controlling shareholder plans to increase its stake by 75 million to 150 million yuan [37] - Tiandi Online's controlling shareholder is transferring shares to introduce a strategic investor [38] Group 15 - Hongchang Technology plans to invest 15 million yuan in a joint venture with a partner [39] - Rabbit Baby's subsidiary is preparing for an IPO in Hong Kong [41] Group 16 - Wol Nuclear Materials is planning to issue H-shares for listing in Hong Kong [42] - Tangyuan Electric plans to raise up to 864 million yuan through a private placement for various projects [43] Group 17 - Tongrun Equipment's major shareholders plan to reduce their holdings by up to 2% [44] - Linzhou Heavy Machinery plans to raise up to 600 million yuan through a private placement [46] Group 18 - China Merchants Securities announced the resignation of its vice president [47] - Shangsheng Electronics plans to issue convertible bonds to raise up to 330 million yuan for various projects [48] Group 19 - Longda Co., Ltd.'s major shareholder plans to reduce its stake by up to 1% [49] - China Medical plans to acquire 100% of Jinsui Technology for 302 million yuan [50] Group 20 - Silek has signed a strategic cooperation agreement with a battery manufacturer [51] - Boyun New Materials' major shareholder plans to reduce its stake by up to 3% [53]

Group 1 - The major shareholder, Wuxi Guolian Industrial Upgrade Investment Center, plans to reduce its stake in Longda Co., Ltd. by up to 2,468,571 shares, which is no more than 1% of the total share capital [1] - As of the announcement date, Guolian holds 21,556,321 shares, accounting for 8.73% of the total share capital [1] - The reduction will occur through centralized bidding within three months after the announcement, with a limit of 1% of total shares in any consecutive 90-day period [1] Group 2 - Longda Co., Ltd. was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on July 22, 2022, with an initial offering price of 39.08 yuan [3] - The company raised a total of 241,179.43 million yuan from its initial public offering, with a net amount of 220,127.16 million yuan, exceeding the original plan by 120,127.16 million yuan [3] - The funds raised are intended for a technical transformation project to increase the annual production of aviation-grade high-temperature alloys by 10,000 tons, a new research and development center, and to supplement working capital [3]

Economic Information - In April, the housing rental industry entered a low season, with the average residential rent in 50 cities decreasing by 0.32% month-on-month to 35.2 yuan per square meter per month, and a year-on-year decline of 3.40% [2] - The global N-type SiC substrate industry is expected to see a revenue decrease of 9% in 2024, amounting to $1.04 billion, due to weakened automotive and industrial demand, increased market competition, and significant price drops [2] Company Alerts - Spring光科技 has announced that its stock is subject to irrational market speculation risk [3] - 博云新材's shareholder 高创投 plans to reduce its stake by no more than 3% [3] - Other companies such as 龙江交通, 海南海药, and 赛摩智能 also have shareholders planning to reduce their stakes by up to 3% [3][5] Overseas Market Alerts - COMEX gold futures fell by 2.76% to $3,240.1 per ounce, while silver futures decreased by 0.42% to $32.775 per ounce [2] - Citigroup forecasts that gold will consolidate in the range of $3,000 to $3,300 per ounce in the coming months, adjusting its 0-3 month target price to $3,150 per ounce [2] - Russia's oil production is expected to recover to 10.8 million barrels per day due to global demand growth and changes in domestic investment and taxation [3]

Company Announcements - Zhaowei Electromechanical plans to reduce its shareholding by no more than 1.5%, equating to approximately 3.6 million shares [1] - China CNR Corporation has signed several major contracts totaling approximately 54.74 billion yuan, representing about 22.2% of its expected revenue for 2024 [2] - Yunnan Copper is planning to acquire a 40% stake in Liangshan Mining, leading to a temporary suspension of its stock [2] - Sunshine Nuohua intends to acquire 100% of Langyan Life, with its stock set to resume trading [3] - Wolong Materials is planning to issue H-shares and apply for a listing on the Hong Kong Stock Exchange [3] - Hanyu Pharmaceutical has signed a joint development agreement for a novel peptide drug targeting metabolic diseases [3] - Lijun Co. confirms that its operations are normal and there are no undisclosed significant matters [3] Investments & Acquisitions - China Medical plans to acquire 100% of Jinsui Technology for 302 million yuan [4] - Shuangyi Technology intends to acquire 100% of Marky Industries for 18 million AUD, along with specific assets [5] Strategic Partnerships - Sileck has signed a strategic cooperation agreement with Lihua Power for the development of large cylindrical batteries [6] - Hongchang Technology plans to invest 15 million yuan in a humanoid robot industry chain company [7] - Macroview Technology is establishing a wholly-owned subsidiary focused on artificial intelligence [8] - Yihua Jiaye has signed a strategic cooperation framework agreement with Hanyu Pharmaceutical and Hanyu Health to develop a sleep health ecosystem [9] - Wanda Film is investing in Lezi Tiancheng and will engage in strategic cooperation in IP toy product development [10] Shareholding Changes - Tiandi Online's controlling shareholder is transferring 6.97% of its shares to introduce a strategic investor [12] - Longjiang Transportation plans to reduce its shareholding by no more than 3% [13] - Boyun New Materials intends to reduce its shareholding by no more than 3% [14] - Tongrun Equipment's major shareholder plans to reduce its stake by no more than 2% [15] Financing & Capital Increase - Tangyuan Electric plans to raise no more than 864 million yuan through a private placement [16] - Shangsheng Electronics intends to issue convertible bonds to raise up to 330 million yuan [17] Other Developments - Xianju Pharmaceutical has obtained a domestic production registration certificate for Dydrogesterone tablets [18] - Rongchang Bio has received a clinical trial application acceptance notice for its antibody-drug conjugate RC278 [19] - Jiangsu Leili's subsidiary Dingzhi Technology is implementing a stock incentive plan [20]